RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:So anything good coming out soonTotally agree that we should all formulate questions. Bombard them, so they know they are leaving gaps wide open for speculation and doubt and have an active gropu of investors who care. This is a way I can act like an owner. I'll spend some time formulating questions from my perspective, but honestly, I'm relying on yours and others expertise here when it comes to science and what all that means.
Wino115 wrote: Our views were heard last year and they acceded about half what we wanted -got a financial type with some Canadian and US market experience, but part of the Canadian business club. I would hope the current Board would not allow extraneous fixed cost employees to enter the company unless and until the prospects for oncology are much clearer around the potential future financial rewards. The IR rebrand has been ok, but without dedicated experienced IR its dormant. Let's see who they get. They likely need oncology success to get someone good.
I am still guessing the Board will shrink down some, let s see. But everyone here should formulate the questions they want answered at next weeks call and submit them. I always submit a few and I think you would do yourself a good service to put the hard questions to management instead of just up here . If you put it professionally and accurately to them, they should read it. There's a lot of issues around strategy they should answer. It can help to specify who you want to address your question to.
Biobob wrote: Can we mandate Wino to lobby our interest to the C suite.... I meen hiring a cheif of staff and still no IR replacement.. Jesus.. how dumb can you be.